TM
ACHV icon

Torren Management’s Achieve Life Sciences ACHV Stock Holding History

Torren Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,870
Closed -$14.3K – 988
2025
Q4 		$14.3K Buy
+2,870
New +$12.5K 0.01% 664

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Torren Management's ACHV Position: Q1 2026 in Review

Torren Management sold out of Achieve Life Sciences (ACHV) in Q1 2026, closing a stake of 2,870 shares — an estimated $14.3K sold.

Torren Management first reported a position in ACHV in Q4 2025 and held it in 1 quarter. The position peaked at $14.3K in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Torren Management reported no remaining Achieve Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Torren Management sold 2,870 Achieve Life Sciences shares in Q1 2026, an estimated $14.3K.
  • Torren Management first reported a position in Achieve Life Sciences in Q4 2025 and held it in 1 quarter.
  • Torren Management's Achieve Life Sciences position peaked at $14.3K in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.